Sadreddini S - Search Results

1

The relation between PI3K/AKT signalling pathway and cancer.

Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. Noorolyai S, et al. Among authors: sadreddini s. Gene. 2019 May 25;698:120-128. doi: 10.1016/j.gene.2019.02.076. Epub 2019 Mar 5. Gene. 2019. PMID: 30849534 Review.

2

miR-193: A new weapon against cancer.

Khordadmehr M, Shahbazi R, Sadreddini S, Baradaran B. Khordadmehr M, et al. Among authors: sadreddini s. J Cell Physiol. 2019 Aug;234(10):16861-16872. doi: 10.1002/jcp.28368. Epub 2019 Feb 19. J Cell Physiol. 2019. PMID: 30779342 Review.

3

PTPN22 Silencing in Human Acute T-Cell Leukemia Cell Line (Jurkat Cell) and its Effect on the Expression of miR-181a and miR-181b.

Baghbani E, Khaze V, Sadreddini S, Mokhtarzadeh A, Mansoori B, Mohammadi A, Vatankhahan V, Toosi P, Baradaran B. Baghbani E, et al. Among authors: sadreddini s. Adv Pharm Bull. 2018 Jun;8(2):277-282. doi: 10.15171/apb.2018.032. Epub 2018 Jun 19. Adv Pharm Bull. 2018. PMID: 30023329 Free PMC article.

4

Restoring of miR-193a-5p Sensitizes Breast Cancer Cells to Paclitaxel through P53 Pathway.

Khordadmehr M, Shahbazi R, Baradaran B, Sadreddini S, Shanebandi D, Hajiasgharzadeh K. Khordadmehr M, et al. Among authors: sadreddini s. Adv Pharm Bull. 2020 Sep;10(4):595-601. doi: 10.34172/apb.2020.071. Epub 2020 Aug 9. Adv Pharm Bull. 2020. PMID: 33072537 Free PMC article.

5

Key microRNAs in the biology of breast cancer; emerging evidence in the last decade.

Khordadmehr M, Shahbazi R, Ezzati H, Jigari-Asl F, Sadreddini S, Baradaran B. Khordadmehr M, et al. Among authors: sadreddini s. J Cell Physiol. 2019 Jun;234(6):8316-8326. doi: 10.1002/jcp.27716. Epub 2018 Nov 13. J Cell Physiol. 2019. PMID: 30422324 Review.

6

Immune checkpoint blockade opens a new way to cancer immunotherapy.

Sadreddini S, Baradaran B, Aghebati-Maleki A, Sadreddini S, Shanehbandi D, Fotouhi A, Aghebati-Maleki L. Sadreddini S, et al. J Cell Physiol. 2019 Jun;234(6):8541-8549. doi: 10.1002/jcp.27816. Epub 2018 Dec 3. J Cell Physiol. 2019. PMID: 30511409 Review.

7

A comprehensive review on miR-451: A promising cancer biomarker with therapeutic potential.

Khordadmehr M, Jigari-Asl F, Ezzati H, Shahbazi R, Sadreddini S, Safaei S, Baradaran B. Khordadmehr M, et al. Among authors: sadreddini s. J Cell Physiol. 2019 Dec;234(12):21716-21731. doi: 10.1002/jcp.28888. Epub 2019 May 29. J Cell Physiol. 2019. PMID: 31140618 Review.

8

miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro.

Karimi L, Zeinali T, Hosseinahli N, Mansoori B, Mohammadi A, Yousefi M, Asadi M, Sadreddini S, Baradaran B, Shanehbandi D. Karimi L, et al. Among authors: sadreddini s. J Cell Physiol. 2019 Nov;234(11):21359-21368. doi: 10.1002/jcp.28745. Epub 2019 Apr 29. J Cell Physiol. 2019. PMID: 31032951

9

The Role of M2000 as an Anti-inflammatory Agent in Toll-Like Receptor 2/microRNA-155 Pathway.

Pourgholi F, Hajivalili M, Razavi R, Esmaeili S, Baradaran B, Movasaghpour AA, Sadreddini S, Goodarzynejad H, Mirshafiey A, Yousefi M. Pourgholi F, et al. Among authors: sadreddini s. Avicenna J Med Biotechnol. 2017 Jan-Mar;9(1):8-12. Avicenna J Med Biotechnol. 2017. PMID: 28090274 Free PMC article.

10

Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer.

Sadreddini S, Safaralizadeh R, Baradaran B, Aghebati-Maleki L, Hosseinpour-Feizi MA, Shanehbandi D, Jadidi-Niaragh F, Sadreddini S, Kafil HS, Younesi V, Yousefi M. Sadreddini S, et al. Immunol Lett. 2017 Jan;181:79-86. doi: 10.1016/j.imlet.2016.11.013. Epub 2016 Dec 1. Immunol Lett. 2017. PMID: 27916629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page